Trulieve Cannabis TRLV
NYSE TRLV
$9.65 +0.18 (+1.90%)
At close: Aug 18, 2026 · 3:59 PM UTC

Trulieve Cannabis (TRLV) EBT Margin (2020 - 2026)

Trulieve Cannabis (TRLV) posted quarterly EBT Margin of 8.79% for Q1 2026, up 197.0% year-over-year from 2.96% in Q1 2025, and up 776.65% quarter-over-quarter from 1.0% in Q4 2025.

Trulieve Cannabis (TRLV) EBT Margin (2020 - 2026) Analysis & Trends

Trulieve Cannabis' EBT Margin history runs 7 years deep, the most recent figure standing at 8.79% for Q1 2026.

  • In Q1 2026, EBT Margin rose 197.0% year-over-year to 8.79%; the TTM figure through Mar 2026 stood at 8.24% (up 561.0% YoY), while the FY2025 annual figure was 7.74%, up 414.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 8.79%, up from 1.0% in the prior quarter.
  • The five-year high for EBT Margin was 12.88% in Q2 2025, with the low at 109.39% in Q2 2023.
  • The 5-year median for EBT Margin is 4.09% (2022), against an average of 3.27%.
  • The sharpest annual moves came in 2023 and 2024: EBT Margin plunged 11782 bps in 2023, then soared 12142 bps in 2024.
  • Trulieve Cannabis' EBT Margin stood at 5.9% in 2022, then surged by 152 bps to 3.07% in 2023, then sank by 239 bps to 4.28% in 2024, then soared by 123 bps to 1.0% in 2025, then soared by 777 bps to 8.79% in 2026.
  • Business Quant data shows TRLV's EBT Margin at 8.79% in Q1 2026, 1.0% in Q4 2025, and 10.17% in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -141.50%
Mar 31, 2026 8.79%
Dec 31, 2025 1.00%
Sep 30, 2025 10.17%
Jun 30, 2025 12.88%
Mar 31, 2025 6.83%
Dec 31, 2024 -4.28%
Sep 30, 2024 -4.52%
Jun 30, 2024 12.03%
Mar 31, 2024 10.73%
Dec 31, 2023 3.07%
Sep 30, 2023 4.99%
Jun 30, 2023 -109.39%
Mar 31, 2023 0.41%
Dec 31, 2022 -5.90%
Sep 30, 2022 -14.98%
Jun 30, 2022 8.43%
Mar 31, 2022 4.09%
Dec 31, 2021 -6.22%
Sep 30, 2021 26.87%